BILL · 2023–24 SESSION
SB 5074: Biomarker testing coverage
Concerning coverage for biomarker testing.
Summary
- Requires insurance coverage for biomarker testing when supported by medical and scientific evidence.
From the Senate Bill Report (Orig.) (SB 5074), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · died in committee
- IntroducedJan 9, 2023
- Out of committeestopped here
- Passed Senate
- Passed House
- Governor
- Law
- Prime sponsor
- Lynda Wilson (R-17)
- Introduced
- January 9, 2023 in the Senate
- Last action
- January 8, 2024
- Companion bill
- HB 1450
- Budget
- Has a fiscal note
AN ACT Relating to coverage for biomarker testing;
Sponsors
Prime sponsor: Lynda Wilson (R-17)
6 co-sponsors (2 Democrats, 4 Republicans)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- By resolution, reintroduced and retained in present status.
- First reading, referred to Health & Long Term Care.
- Prefiled for introduction.
SB 5074 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- SB 5074 (2025–26) Seed contract payment
- SB 5074 (2021–22) Safe station pilot programs
- SB 5074 (2019–20) Presidential electors
- SB 5074 (2017–18) Financial aid eligibility
- SB 5074 (2015–16) Veterans' scoring criteria
- SB 5074 (2013–14) Code enforcement officials
- SB 5074 (2011–12) Body art/piercing, tattooing
- SB 5074 (2009–10) Scoliosis screening